Episode Details
Back to Episodes
Pharmaceutical Executive Daily: Novo Nordisk's Unsolicited Acquisition Proposal
Published 6 months, 2 weeks ago
Description
In today’s Pharmaceutical Executive Daily, we cover Novo Nordisk’s unsolicited proposal to acquire Metsera, renewed legal action against Tylenol’s manufacturer following statements from Robert F. Kennedy Jr., and AbbVie’s stronger 2025 profit outlook driven by immunology demand.